CXCR1 and type 2 diabetes mellitus: The emerging evidence on the potential relevance of CXCR1/2 signaling in the onset and progression of obesity-driven metabolic diseases and related complications is investigated in phase 2 clinical studies in obese Type 2 Diabetes (started at December 2020, EudraCT Nr.